Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. STUB
6. EAT
7. NVDA
8. WYFI
9. ARX
10. BTGO

Go back to Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
LIGAND PHARMA (NASDAQ: LGND) Delayed: 287.43 -5.84 (1.99%)
Previous Close $293.27    52 Week High $139.79 
Open $294.99    52 Week Low $82.07 
Day High $294.99    P/E 668.44 
Day Low $285.24    EPS $0.43 
Volume 79,159